Show
Sort by
-
Reduced mucosa-associated Butyricicoccus activity in patients with ulcerative colitis correlates with aberrant claudin-1 expression
-
Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25–3T studied in an in vitro gut model
-
Reduced Butyricicoccus pullicaecorum levels in mucosa of UC patients correlate with aberrant CLDN1 expression
-
Reduced B. pullicaecorum levels in mucosa of UC patients correlate with aberrant CLDN1 expression
-
- Miscellaneous
- open access
Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease